Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

RENAL MICROCIRCULATION DURING PLATELET-ACTIVATING FACTOR (PAF) ANTAGONIST (BN) ADMINISTRATION

Santos, OFP
Boim, M. A.
Bregman, R.
Draibe, S. A.
Schor, N.

Publication date

May 1988

DOI

10.1016/0090-6980(88)90220-1

Publisher

Elsevier BV

ISSN

0090-6980

Journal

Prostaglandins

Abstract

EPM,DIV NEPHROL DIV,São Paulo,BRAZILEPM,DIV NEPHROL DIV,São Paulo,BRAZILWeb of Scienc

Extracted data

Related items

Role of platelet activating factor in gentamicin and cisplatin nephrotoxicity

Santos, Oscar Fernando Pavão dos
Boim, Mirian Aparecida
Barros, Elvino José Guardão
Schor, Nestor

October 1991

The present study was undertaken to evaluate the effects of platelet activating factor (PAF) antagon...

Glomerular platelet activating factor (PAF) levels and origin in experimental glomerulonephritis

Zanglis, A.
Ζάγκλης, Αντώνιος

January 1990

The renal glomerulus and its various cell types (i.e. mesangial cells, endothelial cells) have been ...

THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Copyright 01987 by The American Society for Pharmacology and Experimental Therapeutics Effect of Platelet Activating Factor Antagonists on Cultured Rat

Mesangial Cells
R. Neuwirth
P. Singhal
J. A. Satriano
P. Braquet
D. Schlondorff

January 1987

Platelet activating factor (PAF; 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a lipid mediator o...

THE EFFECT of PAF-ACETHER ANTAGONIST (BN-52021) ON CYCLOSPORINE (CSA) NEPHROTOXICITY - GLOMERULAR HEMODYNAMIC EVALUATION

Santos, OFP
Boim, M. A.
Bregman, R.
Draibe, S. A.
Schor, N.

May 1988

ESCOLA PAULISTA MED,DIV NEPHROL,BR-04023 São Paulo,SP,BRAZILESCOLA PAULISTA MED,DIV NEPHROL,BR-04023...

Effect of platelet-activating factor antagonist BN 52063 on the nephrotoxicity of cisplatin

Santos, Oscar Fernando Pavão dos
Boim, Mirian Aparecida
Barros, Elvino José Guardão
Pirotzky, Eduardo
Braquet, Pierre
Schor, Nestor

December 1991

Cisplatin (DDP) is an effective anticancer agent that has been successfully applied against various ...

EFFECT OF PLATELET-ACTIVATING FACTOR ANTAGONIST ON CYCLOSPORINE NEPHROTOXICITY - GLOMERULAR HEMODYNAMICS EVALUATION

Dos Santos, Oscar F Pavao
Boim, Mirian A.
Bregman, Rachel
Draibe, Sergio A.
Barros, Elvino JG
Pirotzky, Eduardo
Schor, Nestor
Braquet, Pierre

April 1989

INST HENRI BEAUFOUR,RES LABS,ZA COURTABOEUF,1 AVE TROPIQUES,F-91952 LES ULIS,FRANCEESCOLA PAULISTA M...

Etude de l'excretion de Platelet Activating Factor (PAF) par les neutrophiles humains

Cluzel, Marc

January 1990

SIGLEINIST T 77322 / INIST-CNRS - Institut de l'Information Scientifique et TechniqueFRFranc

Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritis

Bertani, Tullio
Livio, Manuela
Macconi, Daniela
Morigi, Marina
Bisogno, Giovanna
Patrono, Carlo
Remuzzi, Giuseppe

June 1987

Platelet activating factor (PAF) as a mediator of injury in nephrotic nephritis. Release of acetyl g...

GLOMERULAR HEMODYNAMICS and HORMONAL PARTICIPATION ON CYCLOSPORINE NEPHROTOXICITY

Barros, EJG
Boim, Mirian Aparecida
Ajzen, H
Ramos, O. L.
Schor, Nestor

July 1987

ESCOLA PAULISTA MED,DIV NEPHROL,RUA BOTUCATU 740,BR-04023 São Paulo,SP,BRAZILESCOLA PAULISTA MED,DIV...

Potential role of platelet activating factor in acute renal failure

López-Novoa, José M.

May 1999

Potential role of platelet activating factor in acute renal failure. The clinical condition of acute...

Etude du role du Platelet Activating Factor (PAF) dans les interactions cellulaires de la (micro)thrombose pulmonaire et cardiaque d'origine anaphylactique. Modulation par le BN 52021 et ses derives, antagonistes du PAF

Braquet, P.
Vargaftig, B.B.
Fonds de la Recherche et de la Technologie (FRT), 75 - Paris (France)
Inst. Henri Beaufour, 92 - Le Plessis-Robinson (France)
Institut National de la Sante et de la Recherche Medicale (INSERM), 75 - Paris (France). Pharmacologie des Mediateurs de l'Inflammation et de la Thrombose

January 1987

SIGLECNRS AR 12604 / INIST-CNRS - Institut de l'Information Scientifique et TechniqueFRFranc

The Role of Platelet-Activating Factor in Mesangial Pathophysiology.

Reznichenko, Anna
Korstanje, Ron

April 2015

Platelet-activating factor (PAF) is a powerful proinflammatory mediator that displays an exceedingly...

Hypertension Laboratory Studies Platelet Activating Factor Vasoconstriction of Dog Kidney Inhibition by Alprazolam

Philip G. Baer
Lauren
M. Cagen

September 2016

SUMMARY Systemic administration of platelet activating factor (PAF; acetyl glyceryl ether phos-phory...

Nephrotoxicity of Cyclosporine: The Role of Platelet-Activating Factor and Thromboxane

Santos, Oscar Fernando Pavão dos
Boim, Mirian Aparecida
Barros, Elvino José Guardão
Pirotzky, Eduardo
Braquet, Pierre
Schor, Nestor

December 1991

Cyclosporine (CsA), an immunosuppressive agent, is potentially nephrotoxic. We had previously observ...

The Role of Platelet-Activating Factor in Mesangial Pathophysiology

Reznichenko, Anna
Korstanje, Ron

April 2015

Platelet-activating factor (PAF) is a powerful proinflammatory mediator that displays an exceedingly...

Role of platelet activating factor in gentamicin and cisplatin nephrotoxicity

Santos, Oscar Fernando Pavão dos
Boim, Mirian Aparecida
Barros, Elvino José Guardão
Schor, Nestor

October 1991

The present study was undertaken to evaluate the effects of platelet activating factor (PAF) antagon...

Glomerular platelet activating factor (PAF) levels and origin in experimental glomerulonephritis

Zanglis, A.
Ζάγκλης, Αντώνιος

January 1990

The renal glomerulus and its various cell types (i.e. mesangial cells, endothelial cells) have been ...

THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Copyright 01987 by The American Society for Pharmacology and Experimental Therapeutics Effect of Platelet Activating Factor Antagonists on Cultured Rat

Mesangial Cells
R. Neuwirth
P. Singhal
J. A. Satriano
P. Braquet
D. Schlondorff

January 1987

Platelet activating factor (PAF; 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a lipid mediator o...

THE EFFECT of PAF-ACETHER ANTAGONIST (BN-52021) ON CYCLOSPORINE (CSA) NEPHROTOXICITY - GLOMERULAR HEMODYNAMIC EVALUATION

Santos, OFP
Boim, M. A.
Bregman, R.
Draibe, S. A.
Schor, N.

May 1988

ESCOLA PAULISTA MED,DIV NEPHROL,BR-04023 São Paulo,SP,BRAZILESCOLA PAULISTA MED,DIV NEPHROL,BR-04023...

Effect of platelet-activating factor antagonist BN 52063 on the nephrotoxicity of cisplatin

Santos, Oscar Fernando Pavão dos
Boim, Mirian Aparecida
Barros, Elvino José Guardão
Pirotzky, Eduardo
Braquet, Pierre
Schor, Nestor

December 1991

Cisplatin (DDP) is an effective anticancer agent that has been successfully applied against various ...

EFFECT OF PLATELET-ACTIVATING FACTOR ANTAGONIST ON CYCLOSPORINE NEPHROTOXICITY - GLOMERULAR HEMODYNAMICS EVALUATION

Dos Santos, Oscar F Pavao
Boim, Mirian A.
Bregman, Rachel
Draibe, Sergio A.
Barros, Elvino JG
Pirotzky, Eduardo
Schor, Nestor
Braquet, Pierre

April 1989

INST HENRI BEAUFOUR,RES LABS,ZA COURTABOEUF,1 AVE TROPIQUES,F-91952 LES ULIS,FRANCEESCOLA PAULISTA M...

Etude de l'excretion de Platelet Activating Factor (PAF) par les neutrophiles humains

Cluzel, Marc

January 1990

SIGLEINIST T 77322 / INIST-CNRS - Institut de l'Information Scientifique et TechniqueFRFranc

Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritis

Bertani, Tullio
Livio, Manuela
Macconi, Daniela
Morigi, Marina
Bisogno, Giovanna
Patrono, Carlo
Remuzzi, Giuseppe

June 1987

Platelet activating factor (PAF) as a mediator of injury in nephrotic nephritis. Release of acetyl g...

GLOMERULAR HEMODYNAMICS and HORMONAL PARTICIPATION ON CYCLOSPORINE NEPHROTOXICITY

Barros, EJG
Boim, Mirian Aparecida
Ajzen, H
Ramos, O. L.
Schor, Nestor

July 1987

ESCOLA PAULISTA MED,DIV NEPHROL,RUA BOTUCATU 740,BR-04023 São Paulo,SP,BRAZILESCOLA PAULISTA MED,DIV...

Potential role of platelet activating factor in acute renal failure

López-Novoa, José M.

May 1999

Potential role of platelet activating factor in acute renal failure. The clinical condition of acute...

Etude du role du Platelet Activating Factor (PAF) dans les interactions cellulaires de la (micro)thrombose pulmonaire et cardiaque d'origine anaphylactique. Modulation par le BN 52021 et ses derives, antagonistes du PAF

Braquet, P.
Vargaftig, B.B.
Fonds de la Recherche et de la Technologie (FRT), 75 - Paris (France)
Inst. Henri Beaufour, 92 - Le Plessis-Robinson (France)
Institut National de la Sante et de la Recherche Medicale (INSERM), 75 - Paris (France). Pharmacologie des Mediateurs de l'Inflammation et de la Thrombose

January 1987

SIGLECNRS AR 12604 / INIST-CNRS - Institut de l'Information Scientifique et TechniqueFRFranc

The Role of Platelet-Activating Factor in Mesangial Pathophysiology.

Reznichenko, Anna
Korstanje, Ron

April 2015

Platelet-activating factor (PAF) is a powerful proinflammatory mediator that displays an exceedingly...

Hypertension Laboratory Studies Platelet Activating Factor Vasoconstriction of Dog Kidney Inhibition by Alprazolam

Philip G. Baer
Lauren
M. Cagen

September 2016

SUMMARY Systemic administration of platelet activating factor (PAF; acetyl glyceryl ether phos-phory...

Nephrotoxicity of Cyclosporine: The Role of Platelet-Activating Factor and Thromboxane

Santos, Oscar Fernando Pavão dos
Boim, Mirian Aparecida
Barros, Elvino José Guardão
Pirotzky, Eduardo
Braquet, Pierre
Schor, Nestor

December 1991

Cyclosporine (CsA), an immunosuppressive agent, is potentially nephrotoxic. We had previously observ...

The Role of Platelet-Activating Factor in Mesangial Pathophysiology

Reznichenko, Anna
Korstanje, Ron

April 2015

Platelet-activating factor (PAF) is a powerful proinflammatory mediator that displays an exceedingly...

Role of platelet activating factor in gentamicin and cisplatin nephrotoxicity

Santos, Oscar Fernando Pavão dos
Boim, Mirian Aparecida
Barros, Elvino José Guardão
Schor, Nestor

October 1991

The present study was undertaken to evaluate the effects of platelet activating factor (PAF) antagon...

Glomerular platelet activating factor (PAF) levels and origin in experimental glomerulonephritis

Zanglis, A.
Ζάγκλης, Αντώνιος

January 1990

The renal glomerulus and its various cell types (i.e. mesangial cells, endothelial cells) have been ...

THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Copyright 01987 by The American Society for Pharmacology and Experimental Therapeutics Effect of Platelet Activating Factor Antagonists on Cultured Rat

Mesangial Cells
R. Neuwirth
P. Singhal
J. A. Satriano
P. Braquet
D. Schlondorff

January 1987

Platelet activating factor (PAF; 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a lipid mediator o...